Challenges in pharmacodynamic studies of antimicrobial resistance.
作者信息
Rapp Robert P, Campion Jeffrey J
出版信息
Ann Pharmacother. 2003 Sep;37(9):1329-30. doi: 10.1345/aph.1D152.
PMID:12921518
Abstract
摘要
相似文献
1
Challenges in pharmacodynamic studies of antimicrobial resistance.
Ann Pharmacother. 2003 Sep;37(9):1329-30. doi: 10.1345/aph.1D152.
2
Fluoroquinolone AUIC break points and the link to bacterial killing rates: in vitro models.
Ann Pharmacother. 2003 Sep;37(9):1331-4. doi: 10.1345/aph.1D095.
3
Fluoroquinolone benchmarking in relation to pharmacokinetic and pharmacodynamic parameters.
J Antimicrob Chemother. 2003 May;51 Suppl 1:43-7. doi: 10.1093/jac/dkg211.
4
Fluoroquinolone pharmacodynamics.
Clin Infect Dis. 2001 Dec 15;33(12):2091-6. doi: 10.1086/323748.
5
Therapeutic options in an era of decreasing antimicrobial susceptibility.
J Chemother. 2002 Feb;14 Suppl 2:5-12.
6
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update.
J Antimicrob Chemother. 2005 May;55(5):601-7. doi: 10.1093/jac/dki079. Epub 2005 Mar 16.
7
Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
J Vet Pharmacol Ther. 2004 Dec;27(6):503-14. doi: 10.1111/j.1365-2885.2004.00603.x.
8
Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones.
Clin Infect Dis. 2005 Jul 15;41 Suppl 2:S127-35. doi: 10.1086/428053.
9
[Fluoroquinolones--a current review].
Med Monatsschr Pharm. 2001 Jul;24(7):215-25.
10
[Surveillance on antibiotic resistance of Stenotrophomonas maltophilia in Chengdu and Chongqing area].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Jan;35(1):91-3.
Zotero 插件